Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression (R21)
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2017
Price : $35 *
At a glance
- Drugs Sertraline (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 15 Jul 2016 Status changed from recruiting to completed.
- 11 Sep 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 11 Sep 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.